Quinolones represent an extremely successful family of antibacterial drugs that are active against a wide range of multiresistant pathogens since their mode of action is against different molecular targets than other antimicrobial classes. 2) Quinolone antibacterial agents have been known to inhibit DNA gyrase and topoisomerase IV, bacterial topoisomerase II enzymes.
3) DNA topoisomerase II enzyme is an essential cellular enzyme that catalyzes the double strand breakage of DNA to allow strand passage and thereby control the topology and conformation of DNA. 4) Following the discovery of the therapeutic effects of nalidixic acid in the 1970s, medicinal chemists began to probe every position within the quinolone nucleus in an attempt to improve potency, broaden the spectrum of antibacterial activity, and reduce recognized side effects. To date, several thousand related compounds have been synthesized. In the 1980s, the addition both of a fluorine atom at the 6-position and a piperazine substitution at the 7-position of the basic quinolone structure was found to enhance quinolone antibacterial activity, gaining effectiveness against such organisms as Pseudomonas aeruginosa and Gram-positive cocci, and to increase the extent of oral drug absorption and tissue distribution. 5, 6) Norfloxacin 1 (patented in 1978) was the first compound to combine a piperazinyl side chain in position 7 and a fluoro group in position 6. Although the addition of a piperazinyl ring at the 7-position resulted in increased activity against bacteria such as P. aeruginosa and Gram-positive cocci, norfloxacin continued to suffer from poor bioavailability.
7) The addition of a cyclopropyl ring at the N-1 position led to the development of ciprofloxacin 2. While the spectra and antibacterial activities of quinolones such as norfloxacin 1 and ciprofloxacin 2 have been improved to include most Gram-negative bacteria, their activities against Gram-positive bacteria remained limited.
5) The medicinal chemists have synthesized a large number of norfloxacin and ciprofloxacin analogues. With these compounds, there seems to be an inverse relationship between a compound's Gram-positive and Gram-negative activity such that enhanced activity against one often accompanies reduced activity against the other. Another drawback to increased activity is the potential for increased host toxicity. For example, several broad-spectrum quinolones approved for use in human medicine, such as temafloxacin and grepafloxacin, have been voluntarily withdrawn from clinical use as a result of emerging safety concerns. 8) It is known that at least two factors determine the potency of quinolones against bacteria: the transport of the drug into the cells and the inhibition of the target enzyme, DNA gyrase or topoisomerase IV. A substituent on the 7-position would play a key role in both events. 9) Recently, we have synthesized N-substituted piperazinyl quinolones 4 differing from norfloxacin 1, ciprofloxacin 2 or enoxacin 3 ( Fig. 1) solely by the linkage of various 2-(thiophen-2-yl)ethyl groups to the piperazinyl residue at C-7 of the parent drug and explored their antibacterial activities. [10] [11] [12] By considering the considerable activity of N- [2-(thiophen-2-yl) ethyl] piperazinyl quinolone derivatives 4 against Gram-negative and Grampositive bacteria, a new series of N- [2-(thiophen-3-yl) ethyl] derivatives of piperazinyl quinolone (5, Fig. 1 ) were also synthesized and evaluated for antibacterial activity as positional isomers of 4.
Results and Discussion
Chemistry The N- [2-(thiophen-3-yl) ethyl] piperazinyl quinolone analogues 5 were prepared by the synthetic route diagrammed in Fig. 2 . The commercially available ketone 6 was brominated with CuBr 2 in refluxing CHCl 3 -AcOEt to give corresponding a-bromoketone 7.
12) Compound 7 was converted to oxime derivative 8a by stirring with excess of hydroxylamine hydrochloride in methanol at room temperature. Similarly, the O-methyloxime ethers 8b and O-benzyloxime ethers 8c were synthesized by reaction of compound 7 with methoxyamine hydrochloride and O-benzylhydroxylamine hydrochloride, respectively. [10] [11] [12] Reaction of 7-piperazinylquinolones (1, 2 or 3) with 3-(bromoacetyl)thiophene 7 or a-bromooxime derivatives 8a-c in DMF, in the presence of NaHCO 3 at room temperature afforded corresponding ketones 5a-c and oxime derivatives 5d-l, respectively. [10] [11] [12] Accordingly, enoxacin 3 and ciprofloxacin 2 reacted with abromooxime 8a to give exclusively (E)-5d and (E)-5f. However, in the reaction of norfloxacin 1 with a-bromooxime 8a, (E)-and (Z)-isomers of 5e were isolated in approximately a 65/35 ratio based upon comparison of the NMR integration of corresponding peaks from an aliquot of the principal product mixture. Among oxime ether derivatives 5g-l, O-benzyloximes 5j and 5l were isolated as pure (Z)-isomer while all O-methyl oximes 5g-i and O-benzyloxime analog of norfloxacin 5k were obtained as a mixture of (E)-and (Z)-isomers, with (Z)-isomers predominating. Physicochemical data of these compounds are shown in Table 1 . The stereochemistry of the oxime derivatives 5d-l was elucidated by 1 H-NMR spectroscopy. The 1 H-NMR chemical shifts of the methylene and thiophene ring protons for the E and Z isomers of oxime derivatives 5d-l have notable deviations (Table 2) . Experiences in oximes and oxime ethers suggest that proximity to the oxygen of the oxime in the a-syn configuration will deshield the proton and cause a downfield shift in the signals of related protons. [13] [14] [15] The protons of thiophene ring which is syn to the oxime moiety shifted downfield in (E)-isomers. However, this anisotropic deshielding effect is largely dependent of the dihedral angle between the oxime oxygen and the thiophene ring, and proximity of oxime oxygen to the H 2 , H 4 and H 5 protons of thiophene. In contrast, the protons of methylene which is syn to the oxime moiety shifted downfield in (Z)-isomers ( Table 2) .
Antibacterial Activity Compounds 5a-l were evaluated for their antibacterial activity by determination of MIC (minimum inhibitory concentration) values using conventional agar-dilution method.
16) The results of antibacterial and 5g-h are equivalent in antibacterial activity against these microorganisms with respectable activity (MICs 0.78-1.56 mg/ml). More potent compounds 5f and 5i possessed comparable or better activity with respect to the reference drugs norfloxacin and ciprofloxacin against staphylococci.
Compound 5a-i showed moderate or poor activity, expressed as minimal inhibitory concentrations (MIC), against Pseudomonas aeruginosa (MICϾ3.13-100 mg/ml), whereas they exhibited a strong effectiveness towards other Gramnegative bacteria (MICϽ3.13 mg/ml). More significant inhibitory properties were detected for ketone derivative 5c against Escherichia coli (MICϭ0.049 mg/ml) and Klebsiella pneumoniae (MICϭ0.025 mg/ml) as well as towards Pseudomonas aeruginosa at the concentration of 3.13 mg/ml. It is also interesting to note that Gram-positive microorganism Bacillus subtilis was more susceptible to 5c than to 5f (the more potent compound against staphylococci).
Considering the varied structure-activity relationships of different series of compounds, it can be inferred that the antibacterial properties of compounds is determined by the combination influence of N-1 substituent (ethyl or cyclopropyl) and functionality on ethyl linker of thiophene and piperazine. In accordance to previous antibacterial studies, among ketones, oxime, O-methyl oxime and O-benzyl oxime derivatives of (2-oxyiminoethyl) piperazinyl quinolones, lower susceptibilities (higher MICs) were observed with O-benzyl oxime derivatives. Thus, the O-benzyl oxime moiety diminished the activity against both Gram-positive and Gram-negative bacteria. As we can see, the most potent compound against staphylococci (compound 5f) belongs to the oxime series, whereas the most potent compound against Gramnegativies (compound 5c) belongs to the ketone series. Thus, the type of functionality on ethyl spacer has a different influence on antibacterial profile against Gram-positives and Gram-negatives. Comparison between MIC values of ketone analogs 5a-c and their oxime counterpart revealed that alteration of ketone to oxime group caused a significant increase in antibacterial activity against staphylococci only in ciprofloxacin series (5f vs. 5c). In addition, O-methylation or O-benzylation of oxime derivatives could not improved the antibacterial activity. However, in some cases, the presence or introduction of various functional groups in a compound does not allow to accurately explain the kind and intensity of its antibacterial activity.
In conclusion, we have synthesized novel quinolone agents bearing N- [2-(thiophen-3- 
Experimental
Chemicals and all solvents used in this study were purchased from Merck AG and Aldrich Chemical. The 2-bromo-1-(thiophen-3-yl)ethanone 7 and 2-bromo-1-(thiophen-3-yl)ethanone oxime derivatives 8 were prepared according to the literature methods. [10] [11] [12] Melting points were determined on a
Kofler hot stage apparatus (C. Reichert, Vienna, Austria) and are uncorrected. The IR spectra were obtained on a Shimadzu 470 spectrophotometer (potassium bromide disks; Shimadzu, Tokyo, Japan).
1 H-NMR spectra were measured using a Bruker 500 spectrometer (Bruker, Rheinstetten, Germany), and chemical shifts are expressed as d (ppm) with tetramethylsilane as internal standard. Elemental analyses were carried out on a CHN rapid elemental analyzer (GmbH-Germany) for C, H and N, and the results are within Ϯ0.4% of the theoretical values.
General Procedure for the Synthesis of Compounds 5a-l A mixture of 2-bromo-1-(thiophen-3-yl)ethanone 7 or 2-bromo-1-(thiophen-3-yl)-ethanone oxime derivatives 8a-c (0.55 mmol), quinolone 1-3 (0.5 mmol) and NaHCO 3 (0.5 mmol) in DMF (5 ml), was stirred at room temperature for 2-7 d. After consumption of quinolone 1-3, water (20 ml) was added and the precipitate was filtered, washed with water and crystallized from EtOH-CHCl 3 to give compounds 5a-l.
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